May 2017 FDA Recall Benzonatate by Strides Pharma Inc
D-0858-2017 - Failed Stability Specifications

This Class III drug recall was voluntarily initiated by Strides Pharma Inc on May 9, 2017 for the product Benzonatate. The FDA reported the reason for recall as failed stability specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0858-2017

Reason for Recall
Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.
Initiated
05-09-2017
Reported
05-31-2017
Quantity
127,517 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bangaluru -560076 India, Distributed by Strides Pharma Inc East Brunswick, NJ 08816, NDC 64380-713-06

Batch or Lot Expiration Information

Lot# : 7225075, 7225076, 7225077, 7225078, 7225079, 7225080 Exp 7/2017; 7225180, 7225181, 7225322, 7225323, Exp 8/2017; 7225649A, 7225650A , 7225651A , 7225652A, 7225653A, 7225654A, Exp 9/2017